COVID-19: Staging of a New Disease.

COVID-19: Staging of a New Disease.
复制标题

DOI:
10.1016/j.ccell.2020.10.006
复制
发表时间:
2020-11-09
期刊:
影响因子:
50.3
通讯作者:
Reich DL
Reich DL
中科院分区:
医学1区
文献类型:
--
作者:
Cordon-Cardo C;Pujadas E;Wajnberg A;Sebra R;Patel G;Firpo-Betancourt A;Fowkes M;Sordillo E;Paniz-Mondolfi A;Gregory J;Krammer F;Simon V;Isola L;Soon-Shiong P;Aberg JA;Fuster V;Reich DL

文献摘要

参考文献

被引文献

相似文献

2019冠状病毒病(COVID-19)与癌症一样,是一种复杂的疾病,具有临床进展阶段。COVID-19最初被认为是一种呼吸系统疾病,但越来越多地被认为是一种多器官和异质性疾病。疾病分期是一种使用客观的临床和分子标准来测量疾病进展和严重程度的方法。癌症分期不可或缺的是“转移”,其定义为致病因子(包括肿瘤细胞和病原体如某些病毒)从原发部位扩散到不同的解剖位置。分期为患者管理、改善诊断和循证治疗选择方面的临床决策提供了有价值的框架和基准。2019冠状病毒病(COVID-19)与癌症一样,是一种复杂的疾病,具有临床进展阶段。COVID-19最初被认为是一种呼吸系统疾病,但越来越多地被认为是一种多器官和异质性疾病。疾病分期是一种使用客观的临床和分子标准来测量疾病进展和严重程度的方法。癌症分期不可或缺的是“转移”,其定义为致病因子(包括肿瘤细胞和病原体如某些病毒)从原发部位扩散到不同的解剖位置。分期为患者管理、改善诊断和循证治疗选择方面的临床决策提供了有价值的框架和基准。
Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection. Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.
DOI: 10.1016/s2666-5247(20)30120-8
发表时间: 2020-11
期刊: The Lancet. Microbe
影响因子: --
作者:
Wajnberg A;Mansour M;Leven E;Bouvier NM;Patel G;Firpo-Betancourt A;Mendu R;Jhang J;Arinsburg S;Gitman M;Houldsworth J;Sordillo E;Paniz-Mondolfi A;Baine I;Simon V;Aberg J;Krammer F;Reich D;Cordon-Cardo C
通讯作者: Cordon-Cardo C
DOI: 10.1038/s41591-020-1051-9
发表时间: 2020-10
期刊: Nature medicine
影响因子: 82.9
作者:
Del Valle DM;Kim-Schulze S;Huang HH;Beckmann ND;Nirenberg S;Wang B;Lavin Y;Swartz TH;Madduri D;Stock A;Marron TU;Xie H;Patel M;Tuballes K;Van Oekelen O;Rahman A;Kovatch P;Aberg JA;Schadt E;Jagannath S;Mazumdar M;Charney AW;Firpo-Betancourt A;Mendu DR;Jhang J;Reich D;Sigel K;Cordon-Cardo C;Feldmann M;Parekh S;Merad M;Gnjatic S
通讯作者: Gnjatic S
DOI: 10.1093/cid/ciaa1338
发表时间: 2021-08-01
影响因子: 11.8
作者:
Prebensen, Christian;Myhre, Peder L.;Berdal, Jan-Erik
通讯作者: Berdal, Jan-Erik
DOI: 10.1016/j.jacc.2020.08.041
发表时间: 2020-10-20
影响因子: 24
作者:
Nadkarni, Girish N.;Lala, Anuradha;Fuster, Valentin
通讯作者: Fuster, Valentin
DOI: 10.1016/j.ebiom.2020.102925
发表时间: 2020-08-01
期刊: EBIOMEDICINE
影响因子: 11.1
作者:
Leppkes, Moritz;Knopl, Jasmin;Herrmann, Martin
通讯作者: Herrmann, Martin